| Patents for C07D 233 - Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings (34,408) |
|---|
| 03/25/2009 | EP1610790A4 Anticancer compounds |
| 03/25/2009 | EP1353692B1 Methods and compositions for treatment of ocular neovascularization and neural injury |
| 03/25/2009 | EP1221847B1 Methods of enhancing chemotherapy |
| 03/25/2009 | CN101395142A 4-amino-1,5-substituted 1,5-dihydro-imidazol-2-ones |
| 03/25/2009 | CN101395141A Imidazole-based compounds, compositions comprising them and methods of their use |
| 03/25/2009 | CN101395140A Method for producing 2-imidazolidinone compound and 4,5-dialkoxy-2-imidazolidinone compound |
| 03/25/2009 | CN101391973A Salts for adding angiotensin conversion enzyme inhibitors to no-donor acids, method of preparing same and pharmaceutical compositions containing them |
| 03/25/2009 | CN100471880C Polymerisation initiator system |
| 03/25/2009 | CN100471843C Superhigh purity ionic liquid |
| 03/24/2009 | US7507767 Sulfonamide-containing benzene derivatives which exhibit anti-inflammatory and immunodulatory activity |
| 03/24/2009 | US7507757 Substituted heterocyclic derivatives useful as antidiabetic and antiobesity agents and method |
| 03/24/2009 | US7507756 (2-Chlorophenyl)-[2-(1-isopropyl-piperidin-4-ylmethoxy)-3-methyl-3H-imidazol-4-yl]-]-methanone; histamine receptor antagonist; neurologic disorders; reacting imidazole compound with base and perhaloalkane, to form 2-haloimidazole, and with electrophile to form C-5 position substituted imidazole compound |
| 03/24/2009 | US7507546 Using intestinal peptide transporter (PEPT1) and/or kidney peptide transporter (PEPT2) to identify modulators which prevent transfer of sarcosine-glycine dipeptide across cells; drug delivery |
| 03/19/2009 | WO2009035168A1 Sulfonic acid salt compound of 4-carbamoyl-5-hydroxy-imidazole derivative |
| 03/19/2009 | WO2009034390A1 Heterocyclic derivatives and their use in treating hepatitis c |
| 03/19/2009 | US20090076110 An amine salt of nitric acid and aginine, beta alanine, agmatine, citrulline, creatine, glutamine, L-histidine, isoleucine, leucine,norvaline, or ornithine; vasodilation; metabolism of mucle protein;exercise |
| 03/19/2009 | US20090076045 Non-nucleoside reverse transcriptase inhibitors |
| 03/19/2009 | CA2698248A1 F1f0-atpase inhibitors and related methods |
| 03/18/2009 | EP2035393A2 Synthesis and evaluation of 18f-labelled alkyl-1-[(r)-1-phenylethyl]-1h-imidazole-5-carboxylate as a tracer for the quantification of beta-11-hydroxylase enzyme in the adrenal glands |
| 03/18/2009 | EP2035392A1 Imidazole kv1. 5 potassium channel inhibitors |
| 03/18/2009 | EP2035370A2 Tetralin and indane derivatives and uses thereof |
| 03/18/2009 | EP2035367A1 Ship 1 modulator prodrugs |
| 03/18/2009 | EP2034994A2 Nf-kappa b inhibitors and uses thereof |
| 03/18/2009 | EP1581504B1 Process for preparing substituted imidazole derivatives and intermediates used in the process |
| 03/18/2009 | EP1386912B1 Cyclic amidine derivative |
| 03/18/2009 | EP1040094B1 Substituted cyclopentane and cyclopentene compounds useful as neuraminidase inhibitors |
| 03/18/2009 | CN101389609A Hydantoin based kinase inhibitors |
| 03/18/2009 | CN101386599A Hexaarylbisimidazoles compounds, preparation method and application thereof and composition containing thereof |
| 03/18/2009 | CN101386598A New compounds, preparation method and use thereof |
| 03/18/2009 | CN101386597A Alkyl imidazoles perrhenate ion liquid and preparation method thereof |
| 03/17/2009 | US7504542 Preparation of α-hydroxy ketones via carbene-catalyzed umpolung reaction of aldehydes |
| 03/17/2009 | US7504517 1 -(Methylsulfonylamino)-3 - [2-(4-methoxyphenyl)ethyl]-4-(4-methoxyphenyl) -2-imidazolidinone; atrial-selective antiarrhythmic agents; cardiovascular disorders; arrhytmia, atrial fibrillation, atrial flutter, thromboembolism, stroke, and heart failure |
| 03/17/2009 | US7504437 Acetylcholinesterase inhibitor; Alzheimer's diseases, Hubtington disease, antidepressants |
| 03/17/2009 | US7504425 Compounds useful in the treatment of anthrax and inhibiting lethal factor |
| 03/17/2009 | US7504400 MTP inhibiting aryl piperydines or piperazines substituted with 5-membered heterocycles |
| 03/17/2009 | US7504393 Benzylamine analogues |
| 03/17/2009 | CA2433684C Novel couplers for use in oxidative hair dyeing |
| 03/17/2009 | CA2334901C Procedure for producing formyl imidazoles |
| 03/17/2009 | CA2328234C Compounds that inhibit the binding of integrins to their receptors |
| 03/17/2009 | CA2316351C Benzopyran and benzothiopyran derivatives having retinoid antagonist-like activity |
| 03/12/2009 | WO2009030952A2 Phenylcarboxamide derivatives as inhibitors and effectors of the hedgehog pathway |
| 03/12/2009 | WO2009030747A1 Derivatives of n-phenylacetamide, inhibitors of the enzyme soat-1, and pharmaceutical and cosmetic compositions containing them |
| 03/12/2009 | WO2009009480A3 Novel crystals and process of making 5-({[2-amino-3-(4-carbamoyl-2,6-dimethyl-phenyl)-propionyl]-[1-(4-phenyl-1h-imidazol-2-yl)-ethyl]-amino}-methyl)-2-methoxy- benzoic acid |
| 03/12/2009 | US20090069567 Hafnium complexes of heterocyclic organic ligands |
| 03/12/2009 | US20090069342 1-N-amino-2-imidazolidinones and derivatives thereof which are effective as Kv1.5 potassium channel inhibitors providing atrial-selective antiarrhythmic agents; 1-(aminosulfonylamino)-3-[2-(4-methoxyphenyl)ethyl]-4-(3,4-dimethylphenyl)-2-imidazolidinone |
| 03/12/2009 | US20090069322 N-formyl hydroxylamine derivatives as inhibitors of bacterial polypeptide formylase for treating microbial infections |
| 03/12/2009 | US20090068364 Method of surface treatment using imidazole compound |
| 03/12/2009 | CA2698299A1 Derivatives of n-phenylacetamide, inhibitors of the enzyme soat-1, and pharmaceutical and cosmetic compositions containing them |
| 03/11/2009 | EP1753758B1 Mercaptoimidazoles as ccr2 receptor antagonists |
| 03/11/2009 | EP1620440B1 Synthesis of substituted heterocyclic compounds |
| 03/11/2009 | EP1358165B1 Imidazole derivatives |
| 03/11/2009 | EP0976722B1 Benzamidine derivatives |
| 03/11/2009 | CN101384558A Gaba-b receptor modulators |
| 03/11/2009 | CN101384557A Substituted imidazoline derivatives |
| 03/11/2009 | CN101384175A Insecticidal substituted amino heterocyclic and heteroaryl derivatives |
| 03/11/2009 | CN101381346A Nimorazole derivates for therapy |
| 03/10/2009 | US7501522 1-ethyl-3-methylimidazolium chloride mixed with potassium tert-butoxide forming 1-ethyl-3-methylimidazol-2-ylidene, which has been distilled off is brought into contact in the gaseous state with the protic acid |
| 03/10/2009 | US7501510 N,N'-disubstituted thiourea ligand, when complexed with palladium forms a catalyst useful for Heck reaction of arylhalides and olefins and Suzuki cross-coupling reaction of aryl halides with aryl boric acids |
| 03/10/2009 | US7501505 1,1-Dioxo-1,2-dihydro-1 lambda 6-benzo[d]isothiazol-3-one will promote condensation of a nucleoside phosphoramidite and nucleoside monomer or a nascent oligonucleotide; genetic disorder diagnosis; gene expression inhibitors; treating cytomegalo virus; industrial scale |
| 03/10/2009 | US7501445 Imidazolidinone compounds |
| 03/05/2009 | WO2009028727A1 Fluorine-containing organosulfur compound and pesticidal composition comprising the same |
| 03/05/2009 | WO2009028640A1 Method for purifying fluorine compound |
| 03/05/2009 | WO2009027746A1 Heterocyclic amides useful for the treatment of cancer and psoriasis |
| 03/05/2009 | WO2009027450A1 Novel bradykinin b1-antagonists |
| 03/05/2009 | WO2009027250A2 Distillation of ionic liquids |
| 03/05/2009 | WO2009026701A1 Sirtuin inhibitors |
| 03/05/2009 | WO2008140338A4 New ionic pairs with (4-chloro-2-methylphenoxy)acetate and their syntheses |
| 03/05/2009 | US20090062541 Reacting an aryl or heteroaryl halide with a cyanide donor,potassium hexacyanoferrate(II) or (III), in the presence of a copper compound and a 1-alkyl imidazole as a catalyst stabilizer); nontoxic; industrial scale; cost efficiency; chemical intermediates for agrochemicals and pharmaceuticals |
| 03/05/2009 | US20090062530 Substituted arylalkanoic acid derivatives and use thereof |
| 03/05/2009 | US20090060836 Derivatives of 2-nitro-1,3-imidazole coupled to amino acids and deoxyribose useful for the detection of hypoxic biological tissue |
| 03/05/2009 | DE102007041416A1 Destillation ionischer Flüssigkeiten Distillation of ionic liquids |
| 03/05/2009 | CA2697946A1 New bradykinin b1-antagonists |
| 03/05/2009 | CA2696767A1 Heterocyclic amides useful for the treatment of cancer and psoriasis |
| 03/04/2009 | EP2030635A1 Composition for diagnosing amyloid-related disease |
| 03/04/2009 | CN101379040A Muscarinic receptor antagonists |
| 03/04/2009 | CN101379034A Benzamide and heteroarene derivatives as CETP inhibitors |
| 03/04/2009 | CN100465163C Cis-2,4,5-triaryl-imidazolines |
| 03/04/2009 | CN100464853C A carbon nitrogen coupling reaction catalyst composed of heterocycle functional group 1,3 diketone and halogenated univalence copper and use thereof |
| 03/03/2009 | US7498436 Substituted hydroxyethylamines |
| 03/03/2009 | US7498358 Human ADAM-10 inhibitors |
| 03/03/2009 | US7498348 treatment of obesity; administered with or without lipase inhibitor such as orlistat or lipstatin; e.g. N-cyclohexyl-1-(4-chlorophenyl)-2-(2,4-dichlorophenyl)-5-(N-ethyl,N-methylaminomethyl)-1H-imidazole-4-carboxamide |
| 02/26/2009 | WO2009026407A1 Pyrrole compounds having sphingosine-1-phosphate receptor agonist or antagonist biological activity |
| 02/26/2009 | WO2009024607A1 Biodegradable solvents for the chemical industry |
| 02/26/2009 | WO2009007636A3 Novel cationic surfactant, composition containing same, use thereof as conditioner, and cosmetic treatment method |
| 02/26/2009 | WO2008154402A3 Hdac inhibitors and hormone targeted drugs for the treatment of cancer |
| 02/26/2009 | US20090054659 Process to Prepare Sulfonyl Chloride Derivatives |
| 02/26/2009 | US20090054501 Azole compounds used as tuberculostatic and leishmanicide agents |
| 02/26/2009 | US20090054458 Use of a polymorph of flibanserin for treating disease |
| 02/26/2009 | US20090054448 Amino Acid Derivatives as Histone Deacetylase (HDAC) Inhibitors |
| 02/26/2009 | DE102007040243A1 17Beta-Hydroxysteriod-Dehydrogenase Typ1 Inhibitoren zur Behandlung hormonabhängiger Erkrankungen 17beta-dehydrogenase type 1 Hydroxysteriod inhibitors for the treatment of hormone-dependent diseases |
| 02/26/2009 | CA2696429A1 Pyrrole compounds having sphingosine-1-phosphate receptor agonist or antagonist biological activity |
| 02/25/2009 | EP2028209A1 Organic acid catalyst for polylactic acid synthesis |
| 02/25/2009 | EP2027097A1 Improved monomers and polymers carrying imidazole and benzimidazole groupings, and proton exchange membrane containing the same for the production of a fuel cell |
| 02/25/2009 | EP2027096A1 Substituted arylimidaz0l0ne and triaz0l0ne as inhibitors of vasopressin receptors |
| 02/25/2009 | EP1833801B9 Intermediate compounds for the preparation of angiotensin ii receptor antagonists |
| 02/25/2009 | EP1536787A4 Imidazole alkaloids from lepidium meyenii and methods of usage |
| 02/25/2009 | EP1143965B1 Carbocyclic potassium channel inhibitors |
| 02/25/2009 | CN101374832A Use of 4-imidazole derivatives for CNS disorders |
| 02/25/2009 | CN101374810A Modulators of alpha7 nicotinic acetylcholine receptors and therapeutic uses thereof |
| 02/25/2009 | CN101374804A Substituted diphenylethers, -amines, -sulfides and -methanes for the treatment of respiratory disease |